Sage Journals: Discover world-class research

Retricted access

Research article

First published 2019-5

Efficacy of rituximab in refractory RRMS

Pierre Durozard, Adil Maarouf, Clémence Boutiere [...]

Multiple Sclerosis Journal

Open access

Research article

First published 2020-1

Th17 cells increase in RRMS as well as in SPMS,whereas various other phenotypes of Th17 increase in RRMS only

S Kalra, C Lowndes, L Durant [...]

Multiple Sclerosis Journal – Experimental,Translational and Clinical

Retricted access

Research article

First published 2021-4

Prediction of on-treatment disability worsening in RRMS with the MAGNIMS score

Amy Kunchok, Jeannette Lechner-Scott, Franco Granella [...]

Multiple Sclerosis Journal

Retricted access

Research article

First published 2017-4

Defining brain volume cutoffs to identify clinically relevant atrophy in RRMS

Maria Pia Sormani, Ludwig Kappos, Ernst-Wilhelm Radue [...]

Multiple Sclerosis Journal

Open access

Research article

First published 2024-4

Longitudinal enlargement of choroid plexus is associated with chronic lesion expansion and neurodegeneration in RRMS patients

Samuel Klistorner, Michael H Barnett, Chenyu Wang [...]

Multiple Sclerosis Journal

Retricted access

Research article

First published 2021-4

Switching to ocrelizumab in RRMS patients at risk of PML previously treated with extended interval dosing of natalizumab

Chiara Rosa Mancinelli, Cristina Scarpazza, Cinzia Cordioli [...]

Multiple Sclerosis Journal

Retricted access

Research article

First published 2014-10

Evaluating the response to glatiramer acetate in relapsing–remitting multiple sclerosis (RRMS) patients

Jordi Río, Alex Rovira, Mar Tintoré [...]

Multiple Sclerosis Journal

Retricted access

Research article

First published 2021-4

Long-term effect of natalizumab in patients with RRMS: TYSTEN cohort

Kévin Bigaut, Thibaut Fabacher, Laurent Kremer [...]

Multiple Sclerosis Journal

Retricted access

Research article

First published 2019-2

Validating the use of brain volume cutoffs to identify clinically relevant atrophy in RRMS

Francesca Bovis, Nicola De Stefano, Joshua R Steinerman [...]

Multiple Sclerosis Journal

Retricted access

Research article

First published 2012-5

Differential effects of interferon-ß1b on cytokine patterns of CD4+ and CD8+ T cells derived from RRMS and PPMS patients

Sabine Skrzipek, Antje Vogelgesang, Barbara M Bröker [...]

Multiple Sclerosis Journal

Search results